Phase II Narcolepsy Clinical Trial Halted After Severe Adverse Effects
According to a story from Clinical Trials Arena, the pharmaceutical company Takeda recently released findings from its phase II clinical trial. This trial was evaluating the company's investigational drug TAK-994…